Researchers Demonstrate Anticancer Effect Of Mushrooms
6/07/2011
City of Hope researchers have investigated compounds in natural foods for their potential anticancer benefits, with a focus on food items that are easily found in grocery stores to ensure greater access and availability. Shiuan Chen, Ph.D...
New Publication Validates Use Of HE4 In Evaluating Risk Of Ovarian Cancer
6/07/2011
A study recently published online in the journal Clinica Chimica Acta validated the use of the HE4 test and the ROMA (Risk of Ovarian Malignancy Algorithm) algorithm in distinguishing malignant from benign pelvic masses in the Italian population...
People With Parkinson's Disease May Have Double The Risk For Melanoma, A Dangerous Skin Cancer
6/07/2011
An analysis of several studies shows that people with Parkinson's disease have a significantly higher risk of melanoma, the most dangerous type of skin cancer and the leading cause of death from skin diseases. The research is published in the June 7, 2011, print issue of Neurology®, the medical journal of the American Academy of Neurology...
RPCI Physicians Share Research Results At American Society Of Clinical Oncology Meeting
6/07/2011
Roughly 30,000 oncologists have been convening in Chicago over the last few days for the annual meeting of the American Society of Clinical Oncology (ASCO) June 3-7 in Chicago, IL...
Many Patients With Advanced Cancers Get Treatments That Won't Help
6/07/2011
A study of more than 1,000 patients with colon cancer that had spread to distant sites found that one in eight was treated with at least one drug regimen that was not recommended. Those patients were exposed to significant risk without proven benefits, at an estimated cost just for the drugs of more than $2 million...
Queen's Scientists Unlock Potential Of Frog Skin To Treat Cancer
6/07/2011
Scientists at Queen's University Belfast have discovered proteins in frog skins which could be used to treat cancer, diabetes, stroke and transplant patients by regulating the growth of blood vessels...
Metastatic Soft-Tissue Or Bone Sarcomas, Oral Ridaforolimus Improved Progression-Free Survival
6/06/2011
The SUCCEED trial using oral ridaforolimus met its primary endpoint of progression-free survival in patients with metastatic soft-tissue or bone sarcomas who had responded well to chemotherapy, Merck announced at the American Society of Clinical Oncology Annual Meeting in Chicago today. Outside the USA and Canada, Merck is known as MSD or ARIAD Pharmaceuticals...
Among those presenting at this year's American Society of Clinical Oncologists meeting are physician-scientists from NewYork-Presbyterian Hospital/Weill Cornell Medical Center. The meeting takes place June 3-7, at McCormick Place, Chicago. The following are notable research studies: Dr. Mark A...
Veterans Health Administration (VHA) At Least As Good As Private Sector For Cancer Care
6/06/2011
VHA (Veterans Health Administration) services were found to be either similar or better than the private sector for several chronic disease treatments, including cancer, researchers reported in the medical journal Annals of Internal Medicine...
Roche's Pricy Avastin May Slow Ovarian Cancer Progression
6/06/2011
Roche's blockbuster cancer drug Avastin has now additionally been shown to slow the progression of ovarian cancer but does not extend life necessarily according to information presented at this week's American Society of Clinical Oncology annual meeting. A course of treatment with Avastin is priced at about $58,000. The drug, also known as bevacizumab, had sales of $7.8 billion USD last year...